What is CTEPH and am I at risk for getting it?
Have you recently had a pulmonary embolism (PE)? Well this webinar is for you! In a small number of patients who’ve had blood clots in their lungs—a pulmonary embolism (PE)—the clots don’t go away, and you can be at risk of developing CTEPH, or Chronic Thromboembolic Pulmonary Hypertension. CTEPH can be deadly, but is curable!
Sign up for this free webinar & interactive QA session on February 28th, from 7:00pm – 8:00pm EST, to learn more about CTEPH.
William R. Auger, MD
Dr. Auger spent more than 30 years of his career at the University of California San Diego (UCSD) focusing on the evaluation and management of patients with CTEPH and pulmonary disorders and developing one of the leading CTEPH programs in the world. In 2018, Dr. Auger retired from UCSD as a Professor of Clinical Medicine and accepted a faculty appointment at Temple University in Philadelphia until 2021. He now serves as an Emeritus Professor at UCSD.
Kim M. Kerr, MD
Dr. Kerr is Clinical Professor of Medicine and Vice Chief of the Division of Pulmonary, Critical Care & Sleep Medicine at the University of California San Diego. She has been part of the Pulmonary Vascular Program at UCSD since 1993 and her clinical and research interests focus on chronic thromboembolic pulmonary hypertension.
Interested in more information? Check out the rest of the series!
CTEPH & YOU – Part 2: How is CTEPH Diagnosed? This webinar covers how CTEPH and CTEPD are diagnosed.
CTEPH & YOU – Part 3: Medications, Surgery and Catheters…Oh my – CTEPH Treatment Options This webinar covers what can be done for patients with CTEPH, and what happens after a CTEPH diagnosis is made.
Thank you to our program sponsor, Johnson & Johnson Health Care Systems.